China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA: 600062)

China Resources Double-Crane Pharmaceutical Co.,Ltd. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 3, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	20,426	18,992	18,276	13,948	12,508	13,614
Market Cap Growth	35.18%	3.92%	31.03%	11.51%	-8.12%	7.94%
Enterprise Value	19,127	16,381	16,124	11,180	9,405	11,081
Last Close Price	19.90	18.25	17.25	12.39	10.84	11.53
PE Ratio	15.16	14.25	15.49	14.91	12.44	12.90
Forward PE	11.63	12.46	15.32	11.70	9.97	14.94
PS Ratio	1.98	1.86	1.90	1.53	1.47	1.45
PB Ratio	2.01	1.61	1.61	1.33	1.33	1.57
P/TBV Ratio	3.34	2.24	2.29	1.76	1.69	2.04
P/FCF Ratio	18.88	18.50	20.54	16.42	12.36	11.36
P/OCF Ratio	13.30	11.65	12.91	10.40	9.20	9.46
PEG Ratio	0.99	0.99	0.99	0.99	0.99	0.99
EV/Sales Ratio	1.85	1.60	1.68	1.23	1.11	1.18
EV/EBITDA Ratio	8.75	7.83	9.07	7.55	6.08	6.96
EV/EBIT Ratio	12.84	11.09	13.03	10.81	8.02	9.00
EV/FCF Ratio	17.68	15.96	18.13	13.16	9.29	9.25
Debt / Equity Ratio	0.07	0.03	0.03	0.01	-	0.01
Debt / EBITDA Ratio	0.34	0.15	0.16	0.04	-	0.04
Debt / FCF Ratio	0.66	0.30	0.33	0.07	-	0.05
Asset Turnover	0.65	0.67	0.67	0.70	0.72	0.87
Inventory Turnover	2.82	2.66	2.42	2.74	2.59	3.26
Quick Ratio	1.19	1.85	1.79	2.08	2.02	2.03
Current Ratio	1.59	2.42	2.48	2.75	2.55	2.58
Return on Equity (ROE)	12.07%	11.47%	11.32%	9.79%	11.23%	12.86%
Return on Assets (ROA)	5.63%	6.03%	5.36%	4.95%	6.19%	7.13%
Return on Capital (ROIC)	7.67%	7.78%	6.98%	6.49%	8.09%	9.09%
Earnings Yield	6.59%	7.02%	6.46%	6.71%	8.04%	7.75%
FCF Yield	5.30%	5.40%	4.87%	6.09%	8.09%	8.80%
Dividend Yield	1.03%	1.41%	3.35%	3.87%	2.68%	2.64%
Payout Ratio	83.45%	22.95%	67.94%	32.34%	31.77%	28.35%
Buyback Yield / Dilution	0.71%	0.99%	0.74%	-0.00%	-0.00%	0.01%
Total Shareholder Return	1.74%	2.40%	4.09%	3.87%	2.68%	2.64%

Source: S&P Capital IQ. Standard template. Financial Sources.